BRANCHBURG, N.J., Feb. 8 /PRNewswire-FirstCall/ -- LifeCell Corporation , today announced plans to release fourth quarter and full year 2006 operating results on Thursday, March 1, 2007 at 8:00 a.m. Eastern. Paul Thomas, President and Chief Executive Officer, will host a conference call at 10:00 a.m. Eastern, to discuss the Company's fourth quarter and full year 2006 financial results.
The dial-in number for the live call is (877) 704-5386/domestic or (913) 312-1302/international. A simultaneous webcast of the call will be available via LifeCell's website at http://www.lifecell.com Corporate Information -- Investor Relations. The call will be archived on the Company's website for at least 90 days.
A recording of the live-call will be available through March 8, 2007. The dial-in number to listen to the recording is (888) 203-1112 or (719) 457-0820. The replay access code is 1324869.
About LifeCell
LifeCell develops and markets tissue-based products for use in reconstructive, orthopedic and urogynecologic surgical procedures. The Company's core technology produces a unique regenerative tissue matrix that creates the ideal biological framework for organizing the same tissue regeneration process that the body undergoes to repair worn or damaged tissue. LifeCell's current products include: AlloDerm(R) for plastic reconstructive, general surgical, burn and periodontal procedures; Cymetra(R), a particulate form of AlloDerm suitable for injection; GraftJacket(R) for orthopedic applications and lower extremity wounds; AlloCraft(TM)DBM, for bone grafting procedures; and Repliform(R) for urogynecologic surgical procedures. The Company's research and development initiatives include programs focused on extending the use of its regenerative tissue matrix products into new surgical applications, as well as leveraging its core technology to other tissues, including non-human tissues and expanding its product line in the rapidly growing biosurgery market. LifeCell maintains a website at http://www.lifecell.com.
LifeCell CorporationCONTACT: Steven T. Sobieski, Chief Financial Officer of LifeCellCorporation, +1-908-947-1106, ssobieski@lifecell.com; or Kevin McGrath ofCameron Associates, +1-212-245-8800, kevin@cameronassoc.com
Web site: http://www.lifecell.com/
